UniProt ID | TOX4_HUMAN | |
---|---|---|
UniProt AC | O94842 | |
Protein Name | TOX high mobility group box family member 4 | |
Gene Name | TOX4 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 621 | |
Subcellular Localization | Nucleus . Associated with chromatin. | |
Protein Description | Component of the PTW/PP1 phosphatase complex, which plays a role in the control of chromatin structure and cell cycle progression during the transition from mitosis into interphase.. | |
Protein Sequence | MEFPGGNDNYLTITGPSHPFLSGAETFHTPSLGDEEFEIPPISLDSDPSLAVSDVVGHFDDLADPSSSQDGSFSAQYGVQTLDMPVGMTHGLMEQGGGLLSGGLTMDLDHSIGTQYSANPPVTIDVPMTDMTSGLMGHSQLTTIDQSELSSQLGLSLGGGTILPPAQSPEDRLSTTPSPTSSLHEDGVEDFRRQLPSQKTVVVEAGKKQKAPKKRKKKDPNEPQKPVSAYALFFRDTQAAIKGQNPNATFGEVSKIVASMWDSLGEEQKQVYKRKTEAAKKEYLKALAAYKDNQECQATVETVELDPAPPSQTPSPPPMATVDPASPAPASIEPPALSPSIVVNSTLSSYVANQASSGAGGQPNITKLIITKQMLPSSITMSQGGMVTVIPATVVTSRGLQLGQTSTATIQPSQQAQIVTRSVLQAAAAAAAAASMQLPPPRLQPPPLQQMPQPPTQQQVTILQQPPPLQAMQQPPPQKVRINLQQQPPPLQIKSVPLPTLKMQTTLVPPTVESSPERPMNNSPEAHTVEAPSPETICEMITDVVPEVESPSQMDVELVSGSPVALSPQPRCVRSGCENPPIVSKDWDNEYCSNECVVKHCRDVFLAWVASRNSNTVVFVK | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
31 | Phosphorylation | AETFHTPSLGDEEFE CCEECCCCCCCCCCC | 46.25 | 22468782 | |
67 | Phosphorylation | DDLADPSSSQDGSFS HHCCCCCCCCCCCCC | 37.09 | 20058876 | |
111 | Phosphorylation | LTMDLDHSIGTQYSA EEEECCCCCCCCCCC | 23.52 | 26074081 | |
114 | Phosphorylation | DLDHSIGTQYSANPP ECCCCCCCCCCCCCC | 23.75 | 26074081 | |
116 | Phosphorylation | DHSIGTQYSANPPVT CCCCCCCCCCCCCEE | 15.02 | 26074081 | |
155 | Phosphorylation | ELSSQLGLSLGGGTI HHHHHHCCCCCCCCC | 5.34 | 32142685 | |
174 | Phosphorylation | QSPEDRLSTTPSPTS CCHHHHHCCCCCCCC | 31.00 | 29255136 | |
175 | Phosphorylation | SPEDRLSTTPSPTSS CHHHHHCCCCCCCCC | 47.52 | 29255136 | |
176 | Phosphorylation | PEDRLSTTPSPTSSL HHHHHCCCCCCCCCC | 20.56 | 29255136 | |
176 | Ubiquitination | PEDRLSTTPSPTSSL HHHHHCCCCCCCCCC | 20.56 | 33845483 | |
178 | Phosphorylation | DRLSTTPSPTSSLHE HHHCCCCCCCCCCCC | 38.42 | 29255136 | |
180 | Phosphorylation | LSTTPSPTSSLHEDG HCCCCCCCCCCCCCC | 34.97 | 29255136 | |
181 | Phosphorylation | STTPSPTSSLHEDGV CCCCCCCCCCCCCCH | 34.00 | 29255136 | |
182 | Phosphorylation | TTPSPTSSLHEDGVE CCCCCCCCCCCCCHH | 35.90 | 29255136 | |
184 | Acetylation | PSPTSSLHEDGVEDF CCCCCCCCCCCHHHH | 32.80 | - | |
185 | Ubiquitination | SPTSSLHEDGVEDFR CCCCCCCCCCHHHHH | 62.85 | - | |
199 | Ubiquitination | RRQLPSQKTVVVEAG HHHCCCCCEEEECCC | 47.85 | 33845483 | |
199 | Acetylation | RRQLPSQKTVVVEAG HHHCCCCCEEEECCC | 47.85 | 25953088 | |
200 | Phosphorylation | RQLPSQKTVVVEAGK HHCCCCCEEEECCCC | 15.76 | 24505115 | |
207 | Acetylation | TVVVEAGKKQKAPKK EEEECCCCCCCCCCC | 60.11 | 23954790 | |
207 | 2-Hydroxyisobutyrylation | TVVVEAGKKQKAPKK EEEECCCCCCCCCCC | 60.11 | - | |
208 | Acetylation | VVVEAGKKQKAPKKR EEECCCCCCCCCCCC | 56.99 | 26051181 | |
219 | Ubiquitination | PKKRKKKDPNEPQKP CCCCCCCCCCCCCCC | 61.20 | - | |
228 | Phosphorylation | NEPQKPVSAYALFFR CCCCCCCEEEEEEEH | 24.88 | 28555341 | |
232 | Ubiquitination | KPVSAYALFFRDTQA CCCEEEEEEEHHHHH | 2.44 | 32015554 | |
242 | Ubiquitination | RDTQAAIKGQNPNAT HHHHHHHCCCCCCCC | 50.12 | 29967540 | |
255 | Ubiquitination | ATFGEVSKIVASMWD CCHHHHHHHHHHHHH | 46.50 | 32015554 | |
283 | Phosphorylation | TEAAKKEYLKALAAY HHHHHHHHHHHHHHH | 23.53 | 20736484 | |
290 | Phosphorylation | YLKALAAYKDNQECQ HHHHHHHHCCCHHCE | 17.17 | 22817900 | |
311 | Phosphorylation | ELDPAPPSQTPSPPP ECCCCCCCCCCCCCC | 45.70 | 20068231 | |
313 | Phosphorylation | DPAPPSQTPSPPPMA CCCCCCCCCCCCCCC | 30.03 | 20068231 | |
315 | Phosphorylation | APPSQTPSPPPMATV CCCCCCCCCCCCCCC | 54.12 | 20068231 | |
321 | Phosphorylation | PSPPPMATVDPASPA CCCCCCCCCCCCCCC | 21.13 | 20068231 | |
377 | Phosphorylation | ITKQMLPSSITMSQG EEECCCCCCEEECCC | 30.34 | 21955146 | |
378 | Phosphorylation | TKQMLPSSITMSQGG EECCCCCCEEECCCC | 21.82 | 21955146 | |
380 | Phosphorylation | QMLPSSITMSQGGMV CCCCCCEEECCCCEE | 16.84 | 21955146 | |
380 | O-linked_Glycosylation | QMLPSSITMSQGGMV CCCCCCEEECCCCEE | 16.84 | 30059200 | |
382 | O-linked_Glycosylation | LPSSITMSQGGMVTV CCCCEEECCCCEEEE | 19.61 | 30059200 | |
382 | Phosphorylation | LPSSITMSQGGMVTV CCCCEEECCCCEEEE | 19.61 | 20068231 | |
388 | Phosphorylation | MSQGGMVTVIPATVV ECCCCEEEEEECEEE | 12.11 | 21955146 | |
393 | Phosphorylation | MVTVIPATVVTSRGL EEEEEECEEEECCCE | 15.34 | 20068231 | |
396 | Phosphorylation | VIPATVVTSRGLQLG EEECEEEECCCEECC | 14.36 | 21955146 | |
397 | O-linked_Glycosylation | IPATVVTSRGLQLGQ EECEEEECCCEECCC | 16.85 | 30059200 | |
397 | Phosphorylation | IPATVVTSRGLQLGQ EECEEEECCCEECCC | 16.85 | 20068231 | |
405 | O-linked_Glycosylation | RGLQLGQTSTATIQP CCEECCCCCCCCCCH | 26.67 | 30059200 | |
406 | O-linked_Glycosylation | GLQLGQTSTATIQPS CEECCCCCCCCCCHH | 14.25 | 30059200 | |
407 | O-linked_Glycosylation | LQLGQTSTATIQPSQ EECCCCCCCCCCHHH | 31.07 | 30059200 | |
409 | O-linked_Glycosylation | LGQTSTATIQPSQQA CCCCCCCCCCHHHHH | 21.89 | 30059200 | |
413 | O-linked_Glycosylation | STATIQPSQQAQIVT CCCCCCHHHHHHHHH | 20.67 | 30059200 | |
420 | O-linked_Glycosylation | SQQAQIVTRSVLQAA HHHHHHHHHHHHHHH | 20.89 | 30059200 | |
481 | Methylation | QPPPQKVRINLQQQP CCCCCEEEEECCCCC | 21.07 | 24129315 | |
481 | Asymmetric dimethylarginine | QPPPQKVRINLQQQP CCCCCEEEEECCCCC | 21.07 | - | |
494 | Acetylation | QPPPLQIKSVPLPTL CCCCCEEEEECCCCC | 32.23 | 25953088 | |
511 | Phosphorylation | QTTLVPPTVESSPER EEEECCCCCCCCCCC | 30.73 | 29255136 | |
514 | Phosphorylation | LVPPTVESSPERPMN ECCCCCCCCCCCCCC | 47.02 | 26074081 | |
515 | Phosphorylation | VPPTVESSPERPMNN CCCCCCCCCCCCCCC | 19.78 | 26074081 | |
523 | Phosphorylation | PERPMNNSPEAHTVE CCCCCCCCCCCCCCC | 21.07 | 22468782 | |
533 | Phosphorylation | AHTVEAPSPETICEM CCCCCCCCHHHHHHH | 42.28 | 26074081 | |
536 | Phosphorylation | VEAPSPETICEMITD CCCCCHHHHHHHHHH | 34.02 | 26074081 | |
550 | Phosphorylation | DVVPEVESPSQMDVE HHCCCCCCCCCCCEE | 34.72 | 26074081 | |
552 | Phosphorylation | VPEVESPSQMDVELV CCCCCCCCCCCEEEE | 47.63 | 26074081 | |
560 | Phosphorylation | QMDVELVSGSPVALS CCCEEEECCCCCEEC | 46.29 | 26074081 | |
562 | Phosphorylation | DVELVSGSPVALSPQ CEEEECCCCCEECCC | 14.54 | 26074081 | |
567 | Phosphorylation | SGSPVALSPQPRCVR CCCCCEECCCCCCCC | 16.26 | 14702039 | |
575 | Phosphorylation | PQPRCVRSGCENPPI CCCCCCCCCCCCCCC | 27.65 | 26074081 | |
584 | Phosphorylation | CENPPIVSKDWDNEY CCCCCCCCCCCCCCC | 26.14 | 26074081 | |
585 | Acetylation | ENPPIVSKDWDNEYC CCCCCCCCCCCCCCC | 52.52 | 26051181 | |
599 | Acetylation | CSNECVVKHCRDVFL CCCHHHHHHHHHHHH | 19.31 | 26051181 | |
611 | Phosphorylation | VFLAWVASRNSNTVV HHHHHHHCCCCCEEE | 23.52 | 24719451 | |
614 | Phosphorylation | AWVASRNSNTVVFVK HHHHCCCCCEEEEEC | 32.54 | 28555341 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of TOX4_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of TOX4_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of TOX4_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
WDR82_HUMAN | WDR82 | physical | 20516061 | |
PP1A_HUMAN | PPP1CA | physical | 20516061 | |
PP1B_HUMAN | PPP1CB | physical | 20516061 | |
PP1G_HUMAN | PPP1CC | physical | 20516061 | |
TOX4_HUMAN | TOX4 | physical | 20516061 | |
PP1RA_HUMAN | PPP1R10 | physical | 20516061 | |
HSP74_HUMAN | HSPA4 | physical | 20516061 | |
VIME_HUMAN | VIM | physical | 20516061 | |
BANP_HUMAN | BANP | physical | 25416956 | |
MLRA_HUMAN | MYL7 | physical | 25416956 | |
FND3B_HUMAN | FNDC3B | physical | 25416956 | |
GEMI6_HUMAN | GEMIN6 | physical | 25416956 | |
ZMY19_HUMAN | ZMYND19 | physical | 25416956 | |
PP1RA_HUMAN | PPP1R10 | physical | 28514442 | |
KLK7_HUMAN | KLK7 | physical | 28514442 | |
SPA12_HUMAN | SERPINA12 | physical | 28514442 | |
CYTM_HUMAN | CST6 | physical | 28514442 | |
KPRP_HUMAN | KPRP | physical | 28514442 | |
LX12B_HUMAN | ALOX12B | physical | 28514442 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Phosphorylation | |
Reference | PubMed |
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-176; SER-178 ANDTHR-180, AND MASS SPECTROMETRY. | |
"A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-178; THR-180; SER-181AND SER-182, AND MASS SPECTROMETRY. |